PeptiLens
COMPARISON TOOL
Compare up to four entries.
Warning: approved medications, research-use compounds, supplements, cosmetic ingredients, and non-peptide comparison items are not equivalent.
| Field | Abaloparatide | Acetyl tetrapeptide-3 | ACTH | Adrenomedullin |
|---|---|---|---|---|
| Product category | FDA-approved peptide drug or regulated peptide/hormone medication | Cosmetic peptide ingredient | Endogenous peptide or physiological peptide signal | Investigational or clinic-adjacent peptide |
| Mechanism | PTH1 receptor pathway modulation | Cosmetic matrix and hair-appearance claim context | Melanocortin receptor signaling | Calcitonin receptor-like receptor/RAMP pathway signaling |
| Evidence grade | A | C | C | C |
| Human data | FDA label and human clinical evidence for labeled uses | cosmetic or ingredient-level evidence may exist; product-specific review required | physiology and research literature context | not yet fully characterized |
| Safety concerns | 4/5 | 2/5 | 2/5 | 3/5 |
| Regulatory status | Approved | Cosmetic | Unknown | Investigational |
| Approved indications | Osteoporosis treatment in labeled high-risk populations depending on product | None verified | None verified | None verified |
| Sponsor/manufacturer | Multiple manufacturers or historical sponsors | Unknown | Unknown | Unknown |